#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11144	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2172	510.1	0	.	n	.	0	C207T	SNP	207	207	C	468	468	T	630	T,C	424,149	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11144	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2172	510.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1445	1445	C	613	C	579	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20458	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3601	566.2	0	.	n	.	0	T695C	SNP	695	695	T	1003	1003	C	649	C,T	606,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20458	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3601	566.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1946	1946	G	657	G,A	464,144	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20458	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3601	566.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2279	2279	C	585	C	540	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20458	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3601	566.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2353	2353	A	627	A	593	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20458	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3601	566.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2905	2905	C	642	C	607	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1540	folP	855	855	100.0	folP.l15.c17.ctg.1	1485	103.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1028	1030	AGC	161;163;162	A;G;C	147;146;143	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3692	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3469	106.1	1	SNP	p	S91F	1	.	.	271	273	TTC	589	591	TTC	123;123;122	T;T;C	115;116;111	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3692	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3469	106.1	1	SNP	p	D95G	1	.	.	283	285	GGC	601	603	GGC	116;118;118	G;G;C	106;105;105	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3692	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3469	106.1	1	SNP	p	G95N	0	.	.	283	285	GGC	601	603	GGC	116;118;118	G;G;C	106;105;105	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1252	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1275	97.6	1	SNP	p	G45D	0	.	.	133	135	GGC	400	402	GGC	144;143;145	G;G;C,G	132;130;131,1	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	590	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1011	58.1	0	.	n	.	0	A197.	DEL	197	197	A	570	570	A	145	A	138	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3926	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2788	139.8	1	SNP	p	D86N	0	.	.	256	258	GAC	515	517	GAC	179;178;176	G;A;C	160;156;160	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3926	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2788	139.8	1	SNP	p	R87I	0	.	.	259	261	CGT	518	520	CGT	175;173;170	C;G;T	160;158;157	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3926	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2788	139.8	1	SNP	p	S87R	1	.	.	259	261	CGT	518	520	CGT	175;173;170	C;G;T	160;158;157	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3926	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2788	139.8	1	SNP	p	R87W	0	.	.	259	261	CGT	518	520	CGT	175;173;170	C;G;T	160;158;157	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3926	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2788	139.8	1	SNP	p	S88P	0	.	.	262	264	TCC	521	523	TCC	170;170;170	T;C;C	154;157;159	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3368	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2655	126.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1583	1585	GGC	194;193;193	G;G;C	182;183;181	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3134	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	131.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1257	1259	GCC	152;154;156	G;C;C	143;144;147	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3134	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	131.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1260	1262	ATG	155;155;157	A;T;G	145;145;147	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3134	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	131.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1272	1274	ACC	161;160;159	A;C;C	149;151;151	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3134	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	131.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1272	1274	ACC	161;160;159	A;C;C	149;151;151	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3134	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	131.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1773	1775	ACC	157;160;164	A;C;C	139;143;148	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3134	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	131.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1827	1829	GCG	170;170;168	G;C;G	158;160;157	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3134	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	131.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1827	1829	GCG	170;170;168	G;C;G	158;160;157	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3134	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	131.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1950	1952	GGT	129;133;132	G;G;T	120;120;120	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3134	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	131.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1959	1961	AGC	123;122;119	A;G;C	113;111;108	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3134	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2376	131.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1977	1979	CCG	117;119;117	C,G;C;G	89,2;94;90	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4350	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3183	136.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1698	1700	CCG	138;135;134	C;C;G	121;121;117	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1764	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1709	102.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	546	546	C	127	C	114	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2308	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1666	137.7	0	.	p	.	0	I45V	NONSYN	133	135	ATT	546	548	GTT	171;173;174	G;T;T	164;164;166	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2308	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1666	137.7	1	SNP	p	G120K	1	.	.	358	360	AAG	771	773	AAG	184;179;177	A;A;G	171;169;165	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2308	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1666	137.7	1	SNP	p	N121D	0	.	.	361	363	AAC	774	776	AAC	174;175;172	A;A;C	163;164;160	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2308	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1666	137.7	1	SNP	p	A121N	1	.	.	361	363	AAC	774	776	AAC	174;175;172	A;A;C	163;164;160	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8188	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4975	164.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	840	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1020	81.6	1	SNP	p	V57M	1	.	.	169	171	ATG	548	550	ATG	156;155;158	A;T;G	148;147;150	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
